MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0109963
Renocare Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹16.58 Cr
▲ 19% YoY
Net profit · FY 2025
₹90.12 Lakh
Net margin 5.4%
EBITDA · FY 2025
₹1.54 Cr
EBITDA margin 9.3%
Authorised capital
₹18 Lakh
Registered with MCA
Paid-up capital
₹16.73 Lakh
Issued & subscribed
Open charges
₹2.39 Cr
Satisfied ₹40 Lakh
Company age
17 yrs
Est. 2009
Employees · EPFO
120
Provident fund records
About Renocare Pharmaceuticals Private Limited
Data last updated:
Renocare Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2009PTC072103. Its GSTIN is 36AAECR6361G1ZA (Telangana).
The company has an authorised share capital of ₹18 Lakh and a paid-up capital of ₹16.73 Lakh. It is led by directors including Tiruvallur Echambadi Asshok Iyengar (Managing Director) and Vividh Ashok Tiruvallur Echambadi.
Its last annual general meeting (AGM) was held on 21 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.58 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹90.12 Lakh (net margin 5.4%) and EBITDA of ₹1.54 Cr (EBITDA margin 9.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 14% over five years.
The company has about 120 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.39 Cr and satisfied charges of ₹40 Lakh on record.
Renocare Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0109963). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rppl.in.
Company details
CIN U24230TN2009PTC072103
Registration Number 072103
Incorporation Date 26 June 2009
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 21 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0109963
Key People
Tiruvallur Echambadi Asshok Iyengar Managing Director Vividh Ashok Tiruvallur Echambadi Director Ashok Iyengar Harrsha Director Recognitions & Rankings of Renocare Pharmaceuticals
Contact details
Renocare Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is rppl.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlat No.Rf – 6 I Floor Abhi – Ani Terrace Plot No.22 Gangai Amman Koil IV Street, Vadapalani, Chennai, Tamil Nadu, India – 600026
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Renocare Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Renocare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Renocare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Renocare Pharmaceuticals Private Limited, buy the company report.
Financials of Renocare Pharmaceuticals Private Limited
FY 2025 filings availableRenocare Pharmaceuticals Private Limited reported revenue of ₹16.58 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹16.58 Cr ▲ 19%
Net profit · FY 2025
₹90.12 Lakh margin 5.4%
EBITDA · FY 2025
₹1.54 Cr margin 9.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 10%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 761%
3 years · compounded
▼ 14%
5 years · compounded
▼ 8%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 19% growth in the latest year. EBITDA rose 761% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.54 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹90.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.3% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Renocare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Renocare Pharmaceuticals Private Limited
Renocare Pharmaceuticals has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tiruvallur Echambadi Asshok Iyengar | Managing Director | 04 Sep 2016 | 10 Years 2 Months | Current |
| Vividh Ashok Tiruvallur Echambadi | Director | 21 Sep 2022 | 4 Years 1 Months | Current |
| Ashok Iyengar Harrsha | Director | 21 Sep 2022 | 4 Years 1 Months | Current |
| Ashok Hemma | Director | 18 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Renocare Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Strathspey Labs Private Limited | ₹16.61 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Velavan Medical Private Limited | ₹16.61 Cr (FY 2024) | 952.0% | Tuticorin, Tamil Nadu, India | |||
| Perfect Medical Enterprises Private Limited | ₹16.61 Cr (FY 2024) | -8.0% | Chennai, Tamil Nadu, India | |||
| Life Guard Distributors Private Limited | ₹16.59 Cr (FY 2025) | -14.0% | Guwahati, Assam, India | |||
| Renocare Pharmaceuticals Private Limitedthis company | ₹16.58 Cr (FY 2025) | ₹90.12 Lakh | 5.4% | 19.0% | 120 | Chennai, Tamil Nadu, India |
| Matias Healthcare Private Limited | ₹16.55 Cr (FY 2024) | 48.0% | Indore, Madhya Pradesh, India | |||
| Jagrut Pharmaceuticals Private Limited | ₹16.54 Cr (FY 2019) | 7.0% | Aurangabad, Maharashtra, India | |||
| Xena Coronus Health Care Private Limited | ₹16.54 Cr (FY 2025) | 30.0% | Indore, Madhya Pradesh, India |
To see the full peer comparison of Renocare Pharmaceuticals Private Limited, buy the company report.
Auditor
Renocare Pharmaceuticals Private Limited is audited by KKGS and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KKGS and Co | FY 2023 | 012508S |
Shareholding
The shareholding of Renocare Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Renocare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.39 Cr
Satisfied charges
₹40 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2024 | 101027102 | State Bank of India | ₹2 Cr | Open | |
| 30 Oct 2023 | 100848296 | Hdfc Bank Limited | ₹25.11 Lakh | Open | |
| 14 Dec 2021 | 100520261 | Hdfc Bank Limited | ₹13.46 Lakh | Open | |
| 16 Jul 2012 | 10371065 | Axis Bank Limited | ₹40 Lakh | Satisfied |
To see the full charge records of Renocare Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Renocare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Renocare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Renocare Pharmaceuticals Private Limited has a workforce of 120 employees on its EPFO records as of Mar 23, 2024, across 2 active EPFO establishments.
Employee count
120
Active EPFO establishments
2
Employee growth
-4.76%
GST
Renocare Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECR6361G1ZA | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Renocare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Renocare Pharmaceuticals Private Limited has 8 board changes on record since 2016: 4 appointments and 4 cessations. The latest: Cootam Raman Padmalatha ceased to be Director on 12 Jul 2023.
AGM
Renocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records.
Filing
Renocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with State Bank Of India amounted to Rs. 200.00 Lakh with Charge ID 101027102 was registered on 11 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.11 Lakh with Charge ID 100848296 was registered on 30 Oct 2023.
Ceased
Cootam Raman Padmalatha ceased to be Director.
Ceased
Krisshnan Balaji Sampath Venkata ceased to be Director.
Appointed
Ashok Iyengar Harrsha was appointed as Director.
Appointed
Vividh Ashok Tiruvallur Echambadi was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.46 Lakh with Charge ID 100520261 was registered on 14 Dec 2021.
Appointed
Ashok Hemma was appointed as Director.
Ceased
Ashok Iyengar Harrsha ceased to be Director.
Ceased
Vividh Ashok Tiruvallur Echambadi ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
Renocare Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 June 2009 (17+ years old) and is registered under CIN U24230TN2009PTC072103.
Renocare Pharmaceuticals has 4 current directors:
- Tiruvallur Echambadi Asshok Iyengar - Managing Director
- Vividh Ashok Tiruvallur Echambadi - Director
- Ashok Iyengar Harrsha - Director
- Ashok Hemma - Director
The latest financial statements of Renocare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 21 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Renocare Pharmaceuticals is 36AAECR6361G1ZA, registered in Telangana.
The CIN (Corporate Identification Number) of Renocare Pharmaceuticals is U24230TN2009PTC072103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Renocare Pharmaceuticals was incorporated on 26 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Renocare Pharmaceuticals by revenue are Strathspey Labs Private Limited, Velavan Medical Private Limited, Perfect Medical Enterprises Private Limited, Life Guard Distributors Private Limited, Matias Healthcare Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Cootam Raman Padmalatha ceased to be Director on 12 Jul 2023. Krisshnan Balaji Sampath Venkata ceased to be Director on 12 Jul 2023. Ashok Iyengar Harrsha was appointed as Director on 21 Sep 2022. Renocare Pharmaceuticals has 8 board changes on record in total.
Yes, Renocare Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0109963).
Renocare Pharmaceuticals can be reached through the website rppl.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Renocare Pharmaceuticals is at Plat No.Rf – 6 I Floor Abhi – Ani Terrace Plot No.22 Gangai Amman Koil IV Street, Vadapalani, Chennai, Tamil Nadu, India – 600026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages